Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
This piece reviews index funds that pair well with Roth IRA rollovers, emphasizing broad market exposure and cost efficiency for easier long-term growth.
24,239 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
When a tech giant pours billions into warehouse robotics, investors want to know what happens next. This guide breaks...
Tesla's robotaxi just launched in Miami, marking a milestone for autonomous transport. Yet the pilot comes with a del...
Amazon and Shopify posted contrasting Q1 2026 results, underscoring a widening gap between a capital-heavy expansion ...
Copper futures tumbled intraday as supply climbs and demand questions linger. The move pins attention on five NYSE-li...
Viant DSP is navigating a fast-changing ad-tech landscape in 2026. This analysis breaks down Q1 dynamics, what the nu...
As Oklo enters 2026, the Q1 earnings landscape offers clues about its path to commercialization. This guide breaks do...
Linkhome is accelerating its AI-driven lending ambitions by acquiring Mortgage One Group. The deal, slated to close b...
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
Optex Systems faces a pivotal Q2 2026, balancing defense demand with supply chain shifts. This analysis breaks down t...
As investors scan the horizon for regenerative medicine players, Avita (RCEL) faces a pivotal quarter. This guide bre...
NRG Energy unveils a two-pronged plan to expand generation and modernize the grid through BYOP and virtual power plan...